• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于日本多中心研究的肝内胆管结石相关胆管癌的预测因素。

Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study.

机构信息

Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

出版信息

Hepatol Res. 2012 Feb;42(2):166-70. doi: 10.1111/j.1872-034X.2011.00908.x. Epub 2011 Dec 13.

DOI:10.1111/j.1872-034X.2011.00908.x
PMID:22151748
Abstract

AIM

The aim of this study was to delineate predictive factors for cholangiocarcinoma in patients with hepatolithiasis, and to establish optimal management for hepatolithiasis from the viewpoint of carcinogenesis on the basis of a Japanese nationwide survey for hepatolithiasis.

METHODS

The Hepatolithiasis Research Group was organized in 2006 by the Ministry of Health, Labour and Welfare of Japan, and conducted a nationwide survey. The research group collected data on 336 cases of hepatolithiasis in 2006, in a cross-sectional survey involving 2592 institutions in Japan. Predictive factors for cholangiocarcinoma associated with hepatolithiasis were analyzed by univariate and multivariate analyses of clinicopathological and therapeutic factors.

RESULTS

Twenty-three patients had cholangiocarcinoma. Histories of choledocoenterostomy and liver atrophy were found to be significantly predictive factors by multivariate analysis. In 87.5% of cases of cholangiocarcinoma with liver atrophy, cholangiocarcinoma was located in the atrophic lobes. The method of reconstruction did not affect the incidence of cholangiocarcinoma (choledochojejunostomy vs. choledochoduodenostomy; side-to-end vs. side-to-side anastomosis).

CONCLUSIONS

Choledocoenterostomy and liver atrophy may increase the risk of developing cholangiocarcinoma. Choledocoenterostomy is thus contraindicated in patients with hepatolithiasis. An aggressive resection strategy is recommended for an atrophic segment.

摘要

目的

本研究旨在描述肝胆管结石患者发生胆管癌的预测因素,并基于日本全国肝胆管结石调查,从癌变角度出发为肝胆管结石制定最佳治疗方案。

方法

日本厚生劳动省于 2006 年成立了肝胆管结石研究组,并开展了一项全国性调查。该研究组通过横断面调查,在日本的 2592 家机构中收集了 2006 年 336 例肝胆管结石患者的数据。通过对临床病理和治疗因素的单因素和多因素分析,研究肝胆管结石相关胆管癌的预测因素。

结果

23 例患者患有胆管癌。多因素分析显示,胆肠吻合术和肝萎缩史是显著的预测因素。在 87.5%的肝萎缩相关胆管癌病例中,胆管癌位于萎缩的肝叶中。重建方法不影响胆管癌的发生率(胆肠吻合术与胆肠吻合术;端侧吻合与侧侧吻合)。

结论

胆肠吻合术和肝萎缩可能会增加发生胆管癌的风险。因此,肝胆管结石患者应避免胆肠吻合术。对于萎缩段,建议采取积极的切除策略。

相似文献

1
Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study.基于日本多中心研究的肝内胆管结石相关胆管癌的预测因素。
Hepatol Res. 2012 Feb;42(2):166-70. doi: 10.1111/j.1872-034X.2011.00908.x. Epub 2011 Dec 13.
2
Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.与肝胆管结石相关的肝内胆管癌的预测因素:18 年日本全国队列研究。
J Gastroenterol. 2022 May;57(5):387-395. doi: 10.1007/s00535-022-01868-6. Epub 2022 Mar 31.
3
Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.肝内胆管结石:日本40年全国性调查分析
J Hepatobiliary Pancreat Sci. 2014 Sep;21(9):617-22. doi: 10.1002/jhbp.116. Epub 2014 May 14.
4
Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.肝内胆管结石患者肝切除术后胆管癌发生风险的长期转归
World J Surg. 2015 Jun;39(6):1537-42. doi: 10.1007/s00268-015-2965-0.
5
Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.预测与肝内胆管结石相关的并发胆管癌的因素。
Hepatogastroenterology. 2003 Jan-Feb;50(49):8-12.
6
What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?肝内胆管结石并存对胆管癌有何影响?
J Gastroenterol Hepatol. 2002 Sep;17(9):1015-20. doi: 10.1046/j.1440-1746.2002.02779.x.
7
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.肝内胆管结石与肝内胆管癌:综述
World J Gastroenterol. 2015 Dec 28;21(48):13418-31. doi: 10.3748/wjg.v21.i48.13418.
8
A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort.基于日本患者队列中预后因素分析的肝内胆管结石严重程度分类系统的建议。
J Gastroenterol. 2018 Jul;53(7):854-860. doi: 10.1007/s00535-017-1410-6. Epub 2017 Nov 8.
9
Clinical features of hepatolithiasis: analyses of multicenter-based surveys in Japan.肝内胆管结石的临床特征:日本多中心调查分析
Lipids Health Dis. 2015 Oct 17;14:129. doi: 10.1186/s12944-015-0130-2.
10
Incidence of Cholangiocarcinoma with or without Previous Resection of Liver for Hepatolithiasis.胆管癌的发病率,有无先前因肝胆管结石而行的肝脏切除术。
Gut Liver. 2013 Jul;7(4):475-9. doi: 10.5009/gnl.2013.7.4.475. Epub 2013 Apr 9.

引用本文的文献

1
Preoperative SII Can Predict Postoperative Recurrence and Serious Complications in Patients with Hepatolithiasis.术前全身炎症反应指数可预测肝内胆管结石患者术后复发及严重并发症
J Inflamm Res. 2025 Mar 7;18:3321-3331. doi: 10.2147/JIR.S506442. eCollection 2025.
2
Evolution of surgical treatment for hepatolithiasis.肝内胆管结石外科治疗的进展
World J Gastrointest Surg. 2024 Dec 27;16(12):3666-3674. doi: 10.4240/wjgs.v16.i12.3666.
3
Clinical and economic comparison of laparoscopic versus open hepatectomy for primary hepatolithiasis: a propensity score-matched cohort study.
腹腔镜与开腹肝切除术治疗原发性肝胆管结石的临床和经济比较:倾向评分匹配队列研究。
Int J Surg. 2024 Apr 1;110(4):1896-1903. doi: 10.1097/JS9.0000000000001027.
4
Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma.肝内胆管结石的清除可降低胆管癌的风险。
World J Clin Cases. 2024 Apr 16;12(11):1881-1884. doi: 10.12998/wjcc.v12.i11.1881.
5
Evidence-based clinical practice guidelines for cholelithiasis 2021.2021 年胆石病循证临床实践指南。
J Gastroenterol. 2023 Sep;58(9):801-833. doi: 10.1007/s00535-023-02014-6. Epub 2023 Jul 15.
6
Long-term outcomes of anatomic vs. non-anatomic resection in intrahepatic cholangiocarcinoma with hepatolithiasis: A multicenter retrospective study.肝内胆管癌合并肝内胆管结石患者行解剖性切除与非解剖性切除的长期预后:一项多中心回顾性研究
Front Med (Lausanne). 2023 Mar 20;10:1130692. doi: 10.3389/fmed.2023.1130692. eCollection 2023.
7
The Role of microRNAs in Cholangiocarcinoma.微小 RNA 在胆管癌中的作用。
Int J Mol Sci. 2021 Jul 16;22(14):7627. doi: 10.3390/ijms22147627.
8
Hepatolithiasis: clinical series, review and current management strategy.肝内胆管结石:临床系列研究、综述及当前管理策略
Turk J Surg. 2020 Dec 29;36(4):382-392. doi: 10.47717/turkjsurg.2020.4551. eCollection 2020 Dec.
9
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.癌前病变和肝萎缩作为肝切除治疗肝内胆管结石相关死亡的危险因素。
Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3647-3654. doi: 10.31557/APJCP.2020.21.12.3647.
10
Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions.肝门部胆管癌患者的管理策略:挑战与解决方案
Hepat Med. 2020 Jan 23;12:1-13. doi: 10.2147/HMER.S223022. eCollection 2020.